Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Erythra Inc.
Street 2:
City: Stanford
Province: California
Post Code: 94305
Country: United States of America
Phone: 6507147085
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr.
First Name: Mahmoud
Last Name: Rafea
Title: CEO
Phone: +201000200404

Alternate Focal Point Contact Information

Salutation: Ms.
First Name: Heba
Last Name: Badran
Title: CMO
Email: heba,
Phone: 6507147085

General Information

Board Constituency: None
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
Conduct research and development based on the discovery of Erythrocytes Dynamic Antigens Store (EDAS) to manufacture highly reliable medical products for the welfare of human and animal.
Erythra has developed a comprehensive test for diagnosis and treatment monitoring of TB patient.
Erythra TB test will make a difference as it will help in the early diagnosis of TB and detection of cure. This will prevent the escape of patients in the community with the consequent risk of infecting more population.
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Research and Development

Other Organization Information

Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
Erythra will manufacture and distribute an efficient diagnostic tool that will help in fighting TB.

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)
United States of America


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

New Diagnostics:
Erythra introduced a new lateral flow assay based on the quantitative/semi-quantitative estimation of TB antigens in red blood cells cytoplasm (hemolysate).


Declaration of interests:
No conflicts of interest were delacred.

Application date: August 29, 2018
Last updated: August 29, 2018